Ring of Fire: For First Time, FDA Seeks to Ban Opioid For Its Addictive Qualities

Ring of Fire: For First Time, FDA Seeks to Ban Opioid For Its Addictive Qualities

With the strength of the ongoing opioid epidemic, it may come as a surprise that the regulatory agency which oversees the approval of pharmaceuticals is only just now pulling an opioid from the shelves because of its addictive nature.

On Thursday, the FDA announced that they would recalling Opana ER solely because of its likelihood to trigger addiction and cause dependency. Endo Pharmaceuticals, the company that makes Opana ER has been ordered by the FDA to recall the drug.

FDA Commissioner Dr. Scott Gottlieb issued a statement on the decision, openly announcing that the recall was the first of its kind.

Read the Rest at RingofFireRadio.com

Share on FacebookTweet about this on TwitterShare on Google+Digg this

Comments

comments